Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 73

1.

Understanding short bowel syndrome: Current status and future perspectives.

Massironi S, Cavalcoli F, Rausa E, Invernizzi P, Braga M, Vecchi M.

Dig Liver Dis. 2019 Dec 28. pii: S1590-8658(19)30922-3. doi: 10.1016/j.dld.2019.11.013. [Epub ahead of print] Review.

PMID:
31892505
2.

Cell Blood Count Alterations and Patterns of Anaemia in Autoimmune Atrophic Gastritis at Diagnosis: A Multicentre Study.

Lenti MV, Lahner E, Bergamaschi G, Miceli E, Conti L, Massironi S, Cococcia S, Zilli A, Caprioli F, Vecchi M, Maiero S, Cannizzaro R, Corazza GR, Annibale B, Di Sabatino A.

J Clin Med. 2019 Nov 15;8(11). pii: E1992. doi: 10.3390/jcm8111992.

3.

Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study.

Brighi N, Panzuto F, Modica R, Gelsomino F, Albertelli M, Pusceddu S, Massironi S, Lamberti G, Rinzivillo M, Faggiano A, Spallanzani A, Ferone D, Prinzi N, Rossi RE, Annibale B, Colao AM, Campana D.

Oncologist. 2019 Nov 6. pii: theoncologist.2019-0403. doi: 10.1634/theoncologist.2019-0403. [Epub ahead of print]

4.

Nonconventional Doses of Somatostatin Analogs in Patients With Progressing Well-Differentiated Neuroendocrine Tumor.

Lamberti G, Faggiano A, Brighi N, Tafuto S, Ibrahim T, Brizzi MP, Pusceddu S, Albertelli M, Massironi S, Panzuto F, Badalamenti G, Riccardi F, Butturini G, Gelsomino F, De Divitiis C, Modica R, Bongiovanni A, La Salvia A, Torchio M, Colao A, Ferone D, Campana D.

J Clin Endocrinol Metab. 2020 Jan 1;105(1). pii: dgz035. doi: 10.1210/clinem/dgz035.

PMID:
31545377
5.

Effects of low-dose aspirin on clinical outcome and disease progression in patients with gastroenteropancreatic neuroendocrine neoplasm.

Cavalcoli F, Pusceddu S, Zilli A, Tamagno G, Femia D, Prinzi N, Travers J, Consonni D, Ciafardini C, Conte D, Massironi S.

Scand J Gastroenterol. 2019 Sep;54(9):1111-1117. doi: 10.1080/00365521.2019.1656773. Epub 2019 Aug 27.

PMID:
31454281
6.

Tumour type and size are prognostic factors in gastric neuroendocrine neoplasia: A multicentre retrospective study.

Panzuto F, Campana D, Massironi S, Faggiano A, Rinzivillo M, Lamberti G, Sciola V, Lahner E, Manuzzi L, Colao A, Annibale B.

Dig Liver Dis. 2019 Oct;51(10):1456-1460. doi: 10.1016/j.dld.2019.04.016. Epub 2019 Jun 5.

PMID:
31175013
7.

The changing face of chronic autoimmune atrophic gastritis: an updated comprehensive perspective.

Massironi S, Zilli A, Elvevi A, Invernizzi P.

Autoimmun Rev. 2019 Mar;18(3):215-222. doi: 10.1016/j.autrev.2018.08.011. Epub 2019 Jan 11. Review.

PMID:
30639639
8.

Relevance of vitamin D deficiency in patients with chronic autoimmune atrophic gastritis: a prospective study.

Massironi S, Cavalcoli F, Zilli A, Del Gobbo A, Ciafardini C, Bernasconi S, Felicetta I, Conte D, Peracchi M.

BMC Gastroenterol. 2018 Nov 8;18(1):172. doi: 10.1186/s12876-018-0901-0.

9.

Chromogranin A in the Follow-up of Gastroenteropancreatic Neuroendocrine Neoplasms: Is It Really Game Over? A Systematic Review and Meta-analysis.

Rossi RE, Ciafardini C, Sciola V, Conte D, Massironi S.

Pancreas. 2018 Nov/Dec;47(10):1249-1255. doi: 10.1097/MPA.0000000000001184.

PMID:
30325865
10.

Intraductal papillary mucinous neoplasms of the pancreas: a clinical challenge.

Rossi RE, Massironi S.

Expert Rev Gastroenterol Hepatol. 2018 Nov;12(11):1123-1133. doi: 10.1080/17474124.2018.1530111. Epub 2018 Oct 8. Review.

PMID:
30264593
11.

Deficiency of micronutrients in patients affected by chronic atrophic autoimmune gastritis: A single-institution observational study.

Zilli A, Cavalcoli F, Ciafardini C, Massironi S.

Dig Liver Dis. 2019 Apr;51(4):505-509. doi: 10.1016/j.dld.2018.08.028. Epub 2018 Sep 1.

PMID:
30236765
12.

ASO Author Reflections: Heterogeneity of Duodenal Neuroendocrine Tumors.

Massironi S, Rossi RE.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):858-859. doi: 10.1245/s10434-018-6713-1. Epub 2018 Aug 25. No abstract available.

PMID:
30145647
13.

Endoscopic ultrasound appearance of pancreatic serotonin-staining neuroendocrine neoplasms.

Massironi S, Partelli S, Petrone MC, Zilli A, Conte D, Falconi M, Arcidiacono PG.

Pancreatology. 2018 Oct;18(7):792-798. doi: 10.1016/j.pan.2018.08.004. Epub 2018 Aug 11.

PMID:
30115562
14.

Heterogeneity of Duodenal Neuroendocrine Tumors: An Italian Multi-center Experience.

Massironi S, Campana D, Partelli S, Panzuto F, Rossi RE, Faggiano A, Brighi N, Falconi M, Rinzivillo M, Delle Fave G, Colao AM, Conte D.

Ann Surg Oncol. 2018 Oct;25(11):3200-3206. doi: 10.1245/s10434-018-6673-5. Epub 2018 Jul 27.

PMID:
30054824
15.

Effects of a Gluten-Containing Meal on Gastric Emptying and Gallbladder Contraction.

Massironi S, Branchi F, Fraquelli M, Baccarin A, Somalvico F, Ferretti F, Conte D, Elli L.

Nutrients. 2018 Jul 16;10(7). pii: E910. doi: 10.3390/nu10070910.

16.

Morphological Factors Related to Nodal Metastases in Neuroendocrine Tumors of the Appendix: A Multicentric Retrospective Study.

Brighi N, La Rosa S, Rossi G, Grillo F, Pusceddu S, Rinzivillo M, Spada F, Tafuto S, Massironi S, Faggiano A, Antonuzzo L, Santini D, Sessa F, Maragliano R, Gelsomino F, Albertelli M, Vernieri C, Panzuto F, Fazio N, De Divitiis C, Lamberti G, Colao A, Fave GD, Campana D.

Ann Surg. 2018 Jul 10. doi: 10.1097/SLA.0000000000002939. [Epub ahead of print]

PMID:
29995678
17.

Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial.

Caraceni P, Riggio O, Angeli P, Alessandria C, Neri S, Foschi FG, Levantesi F, Airoldi A, Boccia S, Svegliati-Baroni G, Fagiuoli S, Romanelli RG, Cozzolongo R, Di Marco V, Sangiovanni V, Morisco F, Toniutto P, Tortora A, De Marco R, Angelico M, Cacciola I, Elia G, Federico A, Massironi S, Guarisco R, Galioto A, Ballardini G, Rendina M, Nardelli S, Piano S, Elia C, Prestianni L, Cappa FM, Cesarini L, Simone L, Pasquale C, Cavallin M, Andrealli A, Fidone F, Ruggeri M, Roncadori A, Baldassarre M, Tufoni M, Zaccherini G, Bernardi M; ANSWER Study Investigators.

Lancet. 2018 Jun 16;391(10138):2417-2429. doi: 10.1016/S0140-6736(18)30840-7. Epub 2018 Jun 1. Erratum in: Lancet. 2018 Aug 4;392(10145):386.

PMID:
29861076
18.

Duodenal neuroendocrine neoplasms: a still poorly recognized clinical entity.

Rossi RE, Rausa E, Cavalcoli F, Conte D, Massironi S.

Scand J Gastroenterol. 2018 Jun - Jul;53(7):835-842. doi: 10.1080/00365521.2018.1468479. Epub 2018 May 4. Review.

PMID:
29726295
19.

Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms.

Corsello A, Di Filippo L, Massironi S, Sileo F, Dolcetta Capuzzo A, Gemma M, Carlucci C, Cusini C, Colombo B, Dallatomasina A, Franchi GM, Corti A, Manzoni MF.

PLoS One. 2018 May 3;13(5):e0196858. doi: 10.1371/journal.pone.0196858. eCollection 2018.

20.

Neuroendocrine neoplasms of rectum: A management update.

Bertani E, Ravizza D, Milione M, Massironi S, Grana CM, Zerini D, Piccioli AN, Spinoglio G, Fazio N.

Cancer Treat Rev. 2018 May;66:45-55. doi: 10.1016/j.ctrv.2018.04.003. Epub 2018 Apr 6. Review.

PMID:
29684743

Supplemental Content

Loading ...
Support Center